Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) [NA]

View source ↗

Summary

This clinical trial is testing focused ultrasound neuromodulation with Exablate for opioid use disorder and other substance use disorders and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exablate

Snippet

Sponsor: InSightec | Conditions: Opioid-use Disorder, Substance Use Disorders | NA | Status: RECRUITING